510(k) Report

510(k) · Cleared

Cleared

SaliPen

K220618510(k) TraditionalCleared Aug 30, 2022180-day reviewClass II21 CFR 872.5560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Saliwell, Ltd. · QTT Over The Counter Electrical Salivary Stimulatory System

Cleared on Aug 30, 2022 as substantially equivalent to K180838 (Saliwell, Ltd., 2018) after a 180-day review. Its family tree reaches back 3 generations to 1988. 1 later device descends from it.

Decided
Aug 30, 2022
Review
180 days
Class
Class II
Product code
QTT
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to P860067 (1988). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2023: 1 descendant clearedP860067 · Salitron System · Biosonics, Inc. · 1988K160799 · GenNarino · Saliwell, Ltd. · 2017K180838 · SaliPen · Saliwell, Ltd. · 20181990200020102020
Descendants, by generation 1 generation forward: 1 descendant K180838 · SaliPen · Saliwell, Ltd. · 2018K160799 · GenNarino · Saliwell, Ltd. · 2017P860067 · Salitron System · Biosonics, Inc. · 19880
  1. Root · 3 generations backP860067 Salitron SystemBiosonics, Inc. · 1988
  2. 2 generations backK160799 GenNarinoSaliwell, Ltd. · 2017
  3. 1 generation backK180838 SaliPenSaliwell, Ltd. · 2018
  4. This deviceK220618 SaliPenSaliwell, Ltd. · 2022
  5. Descendant · cites it directly · 0 of its ownK232063 SaliPenSaliwell, Ltd. · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K232063SaliPenSaliwell, Ltd. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3P860067Salitron SystemBiosonics, Inc.1988—
−2K160799GenNarinoSaliwell, Ltd.2017—
−1K180838SaliPenSaliwell, Ltd.2018—
0 (this device)K220618SaliPenSaliwell, Ltd.2022—
+1K232063SaliPenSaliwell, Ltd.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K220618, 1988–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QTT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QTT device

  1. #1 K232063 SaliPenscore 7.4 · 4 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K180838SaliPen
Summary page 4
…r system Classification name: Electrical salivary stimulator system Regulatory Class: II Product Code: QTT III. PREDICATE DEVICE The predicate device is SaliPen, K180838. IV. DEVICE DESCRIPTION SaliPen is an electrical salivary stimulatory system device. It is comprised of two units: an in…
Saliwell, Ltd.2018—

Also cleared against K180838: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K232063SaliPenSaliwell, Ltd.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 34 years and passes through 2 companies; a new generation was cleared every 3.8 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K232063 (Saliwell, Ltd., 2023) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K180838.

How does its category compare?

All QTT devices

QTT Over The Counter Electrical Salivary Stimulatory System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QTT

1in 2023

2022: 12023: 1
2007high 1 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QTT

Too few QTT 510(k)s in any year since 2007 to give a median.

Recalls per year · QTT

No recall names QTT since 2007.

Adverse event reports per year · QTT

No MAUDE report names QTT since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20221—00
20231—00
20240—00
20250—00
20260—0—

What is it indicated for?

SaliPen is an electrical salivary stimulator system, indicated for use in patients with xerostomia (dry mouth).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K220618: SaliPen.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K220618

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026